MedTrace Logo

Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes

NCT07553325 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-28

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if knowing risk for diabetes can help adult patients with prediabetes take steps to get care and prevent diabetes. The main questions it aims to answer are:

* Does a shared-decision making visit with a health care team member to talk about the participant's diabetes risk increase participants' taking steps to prevent diabetes?
* Does a simple message in the patient portal about the participant's diabetes risk increase participants' taking steps to prevent diabetes?

Researchers will compare the visit with usual care at the clinic to see if the visit increases participants' taking steps to prevent diabetes. Separately, the researchers will compare the patient message with usual care at the clinic to see if the message increases participants' taking steps to prevent diabetes.

Participants will:

* Complete surveys at the beginning of the study and up to 2 additional surveys
* If the participant falls into the shared decision-making group, the participant will have one 30-minute visit with a healthcare team member to talk about risk of diabetes and how to lower it.

Conditions

  • Prediabetes
  • Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)

Interventions

OTHER

Risk Informed Shared Decision-Making Strategy (RISE)

Single visit with health care team member to discuss diabetes risk and choosing next steps

OTHER

Low Touch Messaging Strategy (LTM)

Single message delivered via patient portal system describing diabetes risk and tips to lower risk

Sponsors & Collaborators

Principal Investigators

  • Eva Tseng, MD, MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-09-01
Completion
2028-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07553325 on ClinicalTrials.gov